Abstract
Derangement in pulmonary surfactant or its components and alveolar collapse are common findings in idiopathic pulmonary fibrosis (IPF). Surfactant proteins play important roles in innate host defense and normal function of the lung. We examined associations between IPF and genetic polymorphic variants of surfactant proteins, SP-A1, SP-A2, SP-B, SP-C, and SP-D. One SP-A1 (6A4) allele and single nucleotide polymorphisms (SNPs) that characterize the 6A4 allele, and one SP-B (B1580_C) were found with higher frequency (P≤0.01) in nonsmoker and smoker IPF (n=84) subgroups, respectively, compared with healthy controls (n=194). To explore whether a tryptophan (present in 6A4) or an arginine (present in other SP-A1 alleles and in all SP-A2 alleles) at amino acid 219 alters protein behavior, two truncated proteins that varied only at amino acid 219 were oxidized by exposure to ozone. Differences in the absorption spectra (310–350 nm) between the two truncated recombinant SP-A proteins were observed both before and after protein oxidation, suggesting allele-specific aggregation differences attributable to amino acid 219. The SP-B SNP B1580_C (odds ratio:7.63; confidence interval:1.64–35.4; P≤0.01), to be a risk factor for IPF smokers, has also been shown to be a risk factor for other pulmonary diseases. The SP-C and SP-D SNPs and SP-B-linked microsatellite markers studied did not associate with IPF. These findings indicate that surfactant protein variants may serve as markers to identify subgroups of patients at risk, and we speculate that these contribute to IPF pathogenesis.
References
Adamson IY, Young L, Bowden DH (1988) Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130:377–383
American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646–664
Barbas-Filho JV, Ferreira MA, Sesso A, Kairalla RA, Carvalho CR, Capelozzi VL (2001) Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol 54:132–138
Beeh KM, Beier J, Haas IC, Kornmann O, Micke P, Buhl R (2002) Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J 19:1119–1123
Behr J, Degenkolb B, Maier K, Braun B, Beinert T, Krombach F, Vogelmeier C, Fruhmann G (1995) Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur Respir J 8:1286–1292
Borron PJ, Mostaghel EA, Doyle C, Walsh ES, McHeyzer-Williams MG, Wright JR (2002) Pulmonary surfactant proteins A and D directly suppress CD3(+)/CD4(+) cell function: evidence for two shared mechanisms. J Immunol 169:5844–5850
Burkhardt A (1989) Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 140:513–524
Cantin AM, Hubbard RC, Crystal RG (1989) Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139:370–372
Chui D, Sellakumar G, Green R, Sutton-Smith M, McQuistan T, Marek K, Morris H, Dell A, Marth J (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA 98:1142–1147
Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA (1995) Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 92:7794–7798
Clark JC, Weaver TE, Iwamoto HS, Ikegami M, Jobe AH, Hull WM, Whitsett JA (1997) Decreased lung compliance and air trapping in heterozygous SP-B- deficient mice. Am J Respir Cell Mol Biol 16:46–52
Collard HR, King TE Jr (2001) Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteroids. Am J Med 110:326–328
DiAngelo S, Lin Z, Wang G, Phillips S, Rämet M, Luo J, Floros J (1999) Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 15:269–281
Fisher JH, Emrie PA, Drabkin HA, Kushnik T, Gerber M, Hofmann T, Jones C (1988) The gene encoding the hydrophobic surfactant protein SP-C is located on 8p and identifies an EcoRI RFLP. Am J Hum Genet 43:436–441
Floros J, Phelps D (1997) Pulmonary surfactant. In: Yaksch TL, Lynch III C, Zapol WM, Maze M, Biebuyck JF, Saidman LJ (eds) Anesthesia: biological foundations. Lippincott-Raven, Philadelphia, pp 1259–1279
Floros J, Phelps DS (2002) Pulmonary surfactant protein A; structure, expression, and its role in innate host defense. Update of Intensive Care Medicine 6:87–102 (English), 103–119 (Greek)
Floros J, Phelps DS, deMello DE, Longmate J, Harding H, Benson B, White T (1991) The utility of postmortem lung for RNA studies; variability and correlation of the expression of surfactant proteins in human lung. Exp Lung Res 17:91–104
Floros J, Veletza SV, Kotikalapudi P, Krizkova L, Karinch AM, Friedman C, Buchter S, Marks K (1995) Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 305:583–590
Floros J, Fan R, DiAngelo S, Guo X, Wert J, Luo J (2001) Surfactant protein (SP) B associations and interactions with SP-A in white and black subjects with respiratory distress syndrome. Pediatr Int 43:567–576
Freeburn RW, Kendall H, Dobson L, Egan J, Simler NJ, Millar AB (2001) The 3' untranslated region of tumor necrosis factor-alpha is highly conserved in idiopathic pulmonary fibrosis (IPF). Eur Cytokine Netw 12:33–38
Freeze HH, Westphal V (2001) Balancing N-linked glycosylation to avoid disease. Biochimie 83:791–799
Garcia-Verdugo I, Wang G, Floros J, Casals C (2002) Structural analysis and lipid-binding properties of recombinant human surfactant protein a derived from one or both genes. Biochemistry 41:14041–14053
Greene KE, King TE Jr, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, Nagae H, Mason RJ (2002) Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 19:439–446
Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA 3rd, Hudson LD, Maunder RJ, Crim C, Hyers TM (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88:1976–1981
Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525
Gunther A, Schmidt R, Nix F, Yabut-Perez M, Guth C, Rosseau S, Siebert C, Grimminger F, Morr H, Velcovsky HG, Seeger W (1999) Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 14:565–573
Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J (2001) Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 18:482–490
Honda T, Ota H, Arai K, Hayama M, Fujimoto K, Yamazaki Y, Haniuda M (2002) Three-dimensional analysis of alveolar structure in usual interstitial pneumonia. Virchows Arch 441:47–52
Hoover RR, Floros J (1998) Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 18:353–362
Hoover RR, Floros J (1999) SP-A 3'-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol 276:L917–L924
Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, Welsh KI, Du Bois RM, Petrek M (2002) Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165:148–151
Kala P, Koptides M, Diangelo S, Hoover RR, Lin Z, Veletza V, Kouretas D, Floros J (1997) Characterization of markers flanking the human SP-B locus. Dis Markers 13:153–167
Karinch AM, deMello DE, Floros J (1997) Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J 321:39–47
Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301–1315
Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA (1996) Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 93:9594–9599
Kremlev SG, Umstead TM, Phelps DS (1994) Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol 267:L357–L364
Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N (1996) P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 154:477–483
Lenz AG, Costabel U, Maier KL (1996) Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur Respir J 9:307–312
Lewis PO, Zaykin D (2001) Genetic data analysis: computer program for the analysis of allelic data. Version 1.0 (d16c). Free program distributed by the authors over the internet from http://lewis.eeb.uconn.edu/lewishome/software.html
Lin Z, deMello DE, Wallot M, Floros J (1998) An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4. Mol Genet Metab 64:25–35
Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, Floros J (2000) Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 58:181–191
Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N (2001) Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur Respir J 17:180–189
Myers JL, Katzenstein AL (1988) Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest 94:1309–1311
Nihlen U, Montnemery P, Lindholm LH, Lofdahl CG (2001) Increased serum levels of carbohydrate-deficient transferrin in patients with chronic obstructive pulmonary disease. Scand J Clin Lab Invest 61:341–347
Nogee LM, Dunbar AE, 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA (2001) A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344:573–579
Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM (2001) Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 163:1432–1436
Phelps DS (2001) Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med 20:269–292
Phelps DS, Umstead TM, Mejia M, Carillo G, Pardo A, Selman M (2003) Increased surfactant protein-A levels in newly diagnosed patients with idopathic pulmonary fibrosis. Chest (in press)
Pison U, Bock JC, Pietschmann S, Veit S, Slama K (1995) The adult respiratory distress syndrome: pathophysiological concepts related to the pulmonary surfactant system. In: Robertson B, Taeusch HW (eds) Surfactant therapy for lung disease. Dekker, New York, pp 167–197
Renzoni E, Lympany P, Sestini P, Pantelidis P, Wells A, Black C, Welsh K, Bunn C, Knight C, Foley P, Du Bois RM (2000) Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 43:1633–1640
Scanlin TF, Glick MC (2001) Glycosylation and the cystic fibrosis transmembrane conductance regulator. Respir Res 2:276–279
Schenk B, Imbach T, Frank CG, Grubenmann CE, Raymond GV, Hurvitz H, Korn-Lubetzki I, Revel-Vik S, Raas-Rotschild A, Luder AS, Jaeken J, Berger EG, Matthijs G, Hennet T, Aebi M (2001) MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest 108:1687–1695
Schmidt R, Meier U, Markart P, Grimminger F, Velcovsky HG, Morr H, Seeger W, Gunther A (2002) Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol 283:L1079–L1085
Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A (2000) TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 279: L562–L574
Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134:136–151
Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S (2000) Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162:1109–1114
Thomas AQ, Lane K, Phillips J 3rd, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, Roberts R, Haines J, Stahlman M, Loyd JE (2002) Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 165:1322–1328
Trask BC, Malone MJ, Lum EH, Welgus HG, Crouch EC, Shapiro SD (2001) Induction of macrophage matrix metalloproteinase biosynthesis by surfactant protein D. J Biol Chem 276:37846–37852
Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M (1998) Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 275:L1192–L1199
Umstead TM, Phelps DS, Wang G, Floros J, Tarkington B (2002) In vitro exposure of proteins to ozone. Toxicol Mech Methods 12:1
Vamvakopoulos NC, Modi WS, Floros J (1995) Mapping the human pulmonary surfactant-associated protein B gene (SFTP3) to chromosome 2p12→p11.2. Cytogenet Cell Genet 68:8–10
Vazquez de Lara L, Becerril C, Montano M, Ramos C, Maldonado V, Melendez J, Phelps DS, Pardo A, Selman M (2000) Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am J Physiol Lung Cell Mol Physiol 279:L950–L957
Vazquez de Lara LG, Umstead TM, Davis SE, Phelps DS (2003) Surfactant protein-A increases matrix metalloproteinase-9 production by THP-1 cells. Am J Physiol Lung Cell Mol Physiol (in press)
Wang G, Phelps DS, Umstead TM, Floros J (2000) Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 278:L946–L954
Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J (2002) The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 110:79–84
Wang G, Christensen ND, Wigdahl B, Guttentag SH, Floros J (2003a) Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease. Biochem J 369:179–184
Wang G, Guo X, Floros J (2003b) Human SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone. Am J Physiol Lung Cell Mol Physiol 284:L738–L748
White MK, Baireddy V, Strayer DS (2001) Natural protection from apoptosis by surfactant protein A in type II pneumocytes. Exp Cell Res 263:183–192
Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A, Fabbri M, Hall I, Britton J, Johnston I, Di Giovine F (2000) Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 162:755–758
Acknowledgements
The authors thank Dr. Makhatadze for the gift of pGIa vector and advice on protein purification, and Sue Myers for typing. This work was supported by NIH R37 HL34788, NIH R01 ES09882, NIH 5T 32RR07066–04 (A.J.), by Philip Morris Incorporated, and by the General Clinical Research Center at the Penn State University, College of Medicine.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Selman, M., Lin, HM., Montaño, M. et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113, 542–550 (2003). https://doi.org/10.1007/s00439-003-1015-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-003-1015-4